Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-1.32 %
$ 22.3 M
Market Cap
-0.27
P/E
LGVN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LGVN - Longeveron Inc.
5.26 M
LAST VALUE
-65.87%
2 YEAR CAGR
31.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR